Qian J, Guo X, Xu Q, Huang Z
J Inflamm Res. 2025; 18:3055-3066.
PMID: 40046681
PMC: 11881767.
DOI: 10.2147/JIR.S497030.
Clain J, Couret D, Bringart M, Meilhac O, Lefebvre dHellencourt C, Diotel N
IBRO Neurosci Rep. 2025; 18():16-30.
PMID: 39816479
PMC: 11733059.
DOI: 10.1016/j.ibneur.2024.12.002.
Ma B, Chan T, Lo B
Surg Neurol Int. 2024; 15:394.
PMID: 39640340
PMC: 11618647.
DOI: 10.25259/SNI_703_2024.
Li Y, Wu J, Du F, Tang T, Lim J, Karuppiah T
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598404
PMC: 11597102.
DOI: 10.3390/ph17111493.
Cheng R, Luo X, Wu X, Wang Z, Chen Z, Zhang S
Adv Sci (Weinh). 2024; 11(48):e2410529.
PMID: 39475454
PMC: 11672321.
DOI: 10.1002/advs.202410529.
A potential role of gut microbiota in stroke: mechanisms, therapeutic strategies and future prospective.
Kaur M, Aran K, Paswan R
Psychopharmacology (Berl). 2024; 241(12):2409-2430.
PMID: 39463207
DOI: 10.1007/s00213-024-06708-4.
Neuroprotective effects of Blume on promoting M2 microglial polarization by inhibiting JNK/TLR4/T3JAM/NF-κB signaling after transient ischemic stroke in rats.
Huang S, Huang H, Liao W, Kao S, Cheng C
Front Pharmacol. 2024; 15:1469602.
PMID: 39391701
PMC: 11465390.
DOI: 10.3389/fphar.2024.1469602.
The effects of self-assembling peptide on glial cell activation.
Hajinejad M, Far B, Gorji A, Sahab-Negah S
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1391-1402.
PMID: 39305327
DOI: 10.1007/s00210-024-03415-x.
Advancements in the mechanisms of Naotai formula in treating stroke: A multi-target strategy.
Shi Y, Ma Y, Liao J
Heliyon. 2024; 10(17):e36748.
PMID: 39296232
PMC: 11408019.
DOI: 10.1016/j.heliyon.2024.e36748.
Microglial heterogeneity in the ischemic stroke mouse brain of both sexes.
Del Aguila A, Zhang R, Yu X, Dang L, Xu F, Zhang J
Genome Med. 2024; 16(1):95.
PMID: 39095897
PMC: 11295600.
DOI: 10.1186/s13073-024-01368-7.
'Comprehensive review of emerging drug targets in traumatic brain injury (TBI): challenges and future scope.
Banderwal R, Kadian M, Garg S, Kumar A
Inflammopharmacology. 2024; 32(5):3271-3293.
PMID: 39023681
DOI: 10.1007/s10787-024-01524-w.
Update on the mechanism of microglia involvement in post-stroke cognitive impairment.
Zeng T, Liu J, Zhang W, Yu Y, Ye X, Huang Q
Front Aging Neurosci. 2024; 16:1366710.
PMID: 38887610
PMC: 11181926.
DOI: 10.3389/fnagi.2024.1366710.
Ischemic stroke outcome after promoting CD4+CD25+ Treg cell migration through CCR4 overexpression in a tMCAO animal model.
Lee S, Kim J, You J, Hyun Y, Kim J, Lee J
Sci Rep. 2024; 14(1):10201.
PMID: 38702399
PMC: 11068779.
DOI: 10.1038/s41598-024-60358-2.
Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19.
Owens C, Pinto C, Detwiler S, Olay L, Pinaffi-Langley A, Mukli P
Brain Commun. 2024; 6(2):fcae080.
PMID: 38495306
PMC: 10943572.
DOI: 10.1093/braincomms/fcae080.
Effects of Banhabaekchulcheonma-Tang on Brain Injury and Cognitive Function Impairment Caused by Bilateral Common Carotid Artery Stenosis in a Mouse Model.
Kim D, Lim J, Cho S, Kim S
Int J Med Sci. 2024; 21(4):644-655.
PMID: 38464836
PMC: 10920841.
DOI: 10.7150/ijms.90167.
Neuroprotection Afforded by an Enriched Mediterranean-like Diet Is Modified by Exercise in a Rat Male Model of Cerebral Ischemia.
Romaus-Sanjurjo D, Castanon-Apilanez M, Lopez-Arias E, Custodia A, Martin-Martin C, Ouro A
Antioxidants (Basel). 2024; 13(2).
PMID: 38397735
PMC: 10885962.
DOI: 10.3390/antiox13020138.
Exosomal miRNAs as Biomarkers of Ischemic Stroke.
Ciaccio A, Tuttolomondo A
Brain Sci. 2023; 13(12).
PMID: 38137095
PMC: 10741776.
DOI: 10.3390/brainsci13121647.
To re-examine the intersection of microglial activation and neuroinflammation in neurodegenerative diseases from the perspective of pyroptosis.
Li Y, Li Y, Zhu Z
Front Aging Neurosci. 2023; 15:1284214.
PMID: 38020781
PMC: 10665880.
DOI: 10.3389/fnagi.2023.1284214.
Fingerprint of Circulating Immunocytes as Biomarkers for the Prognosis of Brain Inflammation and Neuronal Injury after Cardiac Arrest.
Dou H, Brandon N, Koper K, Xu Y
ACS Chem Neurosci. 2023; 14(23):4115-4127.
PMID: 37967214
PMC: 10704468.
DOI: 10.1021/acschemneuro.3c00397.
Integrated inflammatory signaling landscape response after delivering Elovanoid free-fatty-acid precursors leading to experimental stroke neuroprotection.
Reid M, Belayev L, Khoutorova L, Mukherjee P, Obenaus A, Shelvin K
Sci Rep. 2023; 13(1):15841.
PMID: 37740008
PMC: 10516907.
DOI: 10.1038/s41598-023-42126-w.